MUTATIONAL ANALYSIS BEFORE AND AFTER NEOADJUVANT IMATINIB MESYLATE FOR LOCALLY ADVANCED GASTROINTESTINAL STROMAL TUMOURS

被引：0
|
作者：
Lemke, M. [1 ]
Ko, Y. H. [2 ]
Law, C. [1 ]
Haid, V. [1 ]
Rowsell, C.
机构：
[1] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON M4N 3M5, Canada
[2] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：490 / 490
页数：1
相关论文
共 50 条
  • [41] Clinical implications of mutational analysis in gastrointestinal stromal tumours
    Hoeben, A.
    Schoeffski, P.
    Debiec-Rychter, M.
    BRITISH JOURNAL OF CANCER, 2008, 98 (04) : 684 - 688
  • [42] Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach
    Yukinori Kurokawa
    Han-Kwang Yang
    Haruhiko Cho
    Min-Hee Ryu
    Toru Masuzawa
    Sook Ryun Park
    Sohei Matsumoto
    Hyuk-Joon Lee
    Hiroshi Honda
    Oh Kyoung Kwon
    Takashi Ishikawa
    Kyung Hee Lee
    Kazuhito Nabeshima
    Seong-Ho Kong
    Toshio Shimokawa
    Jeong-Hwan Yook
    Yuichiro Doki
    Seock-Ah Im
    Seiichi Hirota
    Seokyung Hahn
    Toshirou Nishida
    Yoon-Koo Kang
    British Journal of Cancer, 2017, 117 : 25 - 32
  • [43] Single Centre Experience of Neoadjuvant Imatinib for Unresectable or Recurrent Gastrointestinal Stromal Tumours
    Smith, Amy
    Beale, Philip
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 : 57 - 57
  • [44] Survival benefit of imatinib mesylate on patients with advanced gastrointestinal stromal tumors (GIST)
    Lin, M. T.
    Hu, T. H.
    Lin, J. W.
    Wang, C. C.
    Rau, K. M.
    Changchien, C. S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A44 - A44
  • [45] Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach
    Kurokawa, Yukinori
    Yang, Han-Kwang
    Cho, Haruhiko
    Ryu, Min-Hee
    Masuzawa, Toru
    Park, Sook Ryun
    Matsumoto, Sohei
    Lee, Hyuk-Joon
    Honda, Hiroshi
    Kwon, Oh Kyoung
    Ishikawa, Takashi
    Lee, Kyung Hee
    Nabeshima, Kazuhito
    Kong, Seong-Ho
    Shimokawa, Toshio
    Yook, Jeong-Hwan
    Doki, Yuichiro
    Im, Seock-Ah
    Hirota, Seiichi
    Hahn, Seokyung
    Nishida, Toshirou
    Kang, Yoon-Koo
    BRITISH JOURNAL OF CANCER, 2017, 117 (01) : 25 - 32
  • [46] Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome
    Wang, Shang-Yu
    Wu, Chiao-En
    Lai, Chun-Chi
    Chen, Jen-Shi
    Tsai, Chun-Yi
    Cheng, Chi-Tung
    Yeh, Ta-Sen
    Yeh, Chun-Nan
    CANCERS, 2019, 11 (03)
  • [47] Is there a role for post-imatinib surgery in advanced gastrointestinal stromal tumours?
    Kuhlmann, K. F. D.
    Kerst, J. M.
    Cats, A.
    van Coevorden, F.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (03) : A3 - A3
  • [48] Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: a potential diagnostic pitfall
    Pauwels, P
    Debiec-Rychter, M
    Stul, M
    De Wever, I
    Van Oosterom, AT
    Sciot, R
    HISTOPATHOLOGY, 2005, 47 (01) : 41 - 47
  • [49] Use of imatinib mesylate in gastrointestinal stromal tumours:: Pan-Birmingham Cancer Network Experience
    Wong, D. W. Y.
    Lupton, S. C.
    Bhatt, L.
    Gross, L.
    Taniere, P.
    Peake, D. R.
    Spooner, D.
    Geh, J. I.
    CLINICAL ONCOLOGY, 2008, 20 (07) : 517 - 522
  • [50] A Giant Gastric Gastrointestinal Stromal Tumor Successfully Resected Following Neoadjuvant Treatment With Imatinib Mesylate
    Takahashi, Ryo
    Toyokawa, Takahiro
    Yoshii, Mami
    Tamura, Tatsuro
    Tanaka, Hiroaki
    Lee, Shigeru
    Muguruma, Kazuya
    Yashiro, Masakazu
    Ohira, Masaichi
    ANTICANCER RESEARCH, 2020, 40 (02) : 1147 - 1152
12345